Definitive Healthcare Corp. (DH)
NASDAQ: DH · Real-Time Price · USD
0.8024
-0.0120 (-1.47%)
At close: Aug 28, 2026, 4:00 PM EDT
0.8200
+0.0176 (2.19%)
After-hours: Aug 28, 2026, 6:27 PM EDT
Definitive Healthcare Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 232.7 | 241.52 | 252.2 | 251.42 | 222.65 | 166.15 | |
Revenue Growth | -4.99% | -4.23% | 0.31% | 12.92% | 34.00% | 40.43% |
Cost of Revenue | 37.79 | 37.95 | 40.68 | 34.74 | 25.87 | 19.42 |
Gross Profit | 194.92 | 203.57 | 211.52 | 216.68 | 196.79 | 146.73 |
Selling, General & Admin | 128.83 | 133.26 | 133.07 | 153.4 | 141.15 | 89.25 |
Research & Development | 30.76 | 34.78 | 36.52 | 42.44 | 34.89 | 18.57 |
Amortization of Goodwill & Intangibles | 19.83 | 20.29 | 14.05 | 12.74 | 16.76 | 21.27 |
Operating Expenses | 214.57 | 224.15 | 221.26 | 247.59 | 232.94 | 167.76 |
Operating Income | -19.65 | -20.58 | -9.74 | -30.91 | -36.15 | -21.03 |
Interest Expense | -11.12 | -11.29 | -14.84 | -15.2 | -11.2 | -25.9 |
Interest & Investment Income | 5.7 | 6.95 | 14.59 | 13.64 | 2.79 | 0.03 |
Currency Exchange Gain (Loss) | 0.2 | -1.9 | 0.4 | -0.3 | - | - |
Other Non Operating Income (Expenses) | 10.52 | 21.76 | 76.92 | 23.48 | 10.58 | 0.29 |
EBT Excluding Unusual Items | -14.35 | -5.06 | 67.33 | -9.29 | -33.99 | -46.61 |
Merger & Restructuring Charges | -10.23 | -11.59 | -14.01 | -11.19 | -6.64 | -2.52 |
Impairment of Goodwill | -216.75 | -196.06 | -688.85 | -287.4 | - | - |
Other Unusual Items | 3.28 | 3.46 | 1.78 | -0.3 | -1.25 | -13.64 |
Pretax Income | -238.05 | -209.26 | -633.75 | -308.18 | -41.88 | -62.77 |
Income Tax Expense | -3.31 | -9.96 | -42.3 | -18.55 | -17.7 | -0.44 |
Earnings From Continuing Operations | -234.75 | -199.3 | -591.45 | -289.63 | -24.18 | -62.32 |
Minority Interest in Earnings | 66.55 | 60.37 | 178.32 | 87.24 | 16.96 | 10.42 |
Net Income | -168.2 | -138.93 | -413.12 | -202.39 | -7.22 | -51.91 |
Preferred Dividends & Other Adjustments | - | - | - | - | - | -34.07 |
Net Income to Common | -168.2 | -138.93 | -413.12 | -202.39 | -7.22 | -17.84 |
Net Income Growth | - | - | - | - | - | - |
Shares Outstanding (Basic) | 104 | 107 | 117 | 113 | 101 | 92 |
Shares Outstanding (Diluted) | 104 | 107 | 117 | 113 | 101 | 92 |
Shares Change | -7.41% | -8.56% | 3.44% | 11.52% | 10.01% | -28.01% |
EPS (Basic) | -1.61 | -1.30 | -3.54 | -1.79 | -0.07 | -0.19 |
EPS (Diluted) | -1.61 | -1.30 | -3.54 | -1.79 | -0.07 | -0.19 |
EPS Growth | - | - | - | - | - | - |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | 28.56 | 37.06 | 45.85 | 38.21 | 27.25 | 18.48 |
Free Cash Flow Per Share | 0.27 | 0.35 | 0.39 | 0.34 | 0.27 | 0.20 |
Gross Margin | 83.76% | 84.28% | 83.87% | 86.18% | 88.38% | 88.31% |
Operating Margin | -8.45% | -8.52% | -3.86% | -12.29% | -16.24% | -12.66% |
Profit Margin | -72.28% | -57.52% | -163.81% | -80.50% | -3.24% | -10.74% |
Free Cash Flow Margin | 12.27% | 15.34% | 18.18% | 15.20% | 12.24% | 11.12% |
EBITDA | 35.33 | 35.53 | 41.93 | 20.84 | 20.75 | 38.92 |
EBITDA Margin | 15.18% | 14.71% | 16.62% | 8.29% | 9.32% | 23.42% |
D&A For EBITDA | 54.98 | 56.11 | 51.67 | 51.75 | 56.9 | 59.95 |
EBIT | -19.65 | -20.58 | -9.74 | -30.91 | -36.15 | -21.03 |
EBIT Margin | -8.45% | -8.52% | -3.86% | -12.29% | -16.24% | -12.66% |
Advertising Expenses | - | 2.1 | 1.9 | 1.6 | 1.6 | 0.9 |